Literature DB >> 28405919

Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.

Yanni Hua1, Chaomeng Wang1, Huijuan Jiang1, Yihao Wang1, Chunyan Liu1, Lijuan Li1, Hui Liu1, Zonghong Shao1, Rong Fu2.   

Abstract

The objective of the study was to examine levels of intracellular iron, reactive oxygen species (ROS) and the expression of JNK and p38MAPK in NK cells and hematopoietic stem/progenitor cells (HSPCs) in MDS patients, and explore potential mechanisms by which iron overload (IOL) promotes MDS progression. Thirty-four cases of MDS and six cases of AML transformed from MDS (MDS/AML) were included. HSPCs and NK cells were isolated by magnetic absorption cell sorting. We used flow cytometry to detect the levels of ROS and intracellular JNK and P38 in NK cells and HSPCs. Total RNA and protein were extracted from NK cells and CD34+ cells to examine the expression of JNK and p38MAPK using RT-PCR and Western blotting. Intracellular iron concentration was detected. Data were analyzed by SPSS 21 statistical software. Intracellular iron concentration and ROS were increased in both NK cells and HSPCs in MDS patients with iron overload (P < 0.05). MDS patients with iron overload had higher JNK expression and lower p38 expression in NK cells, and higher p38 expression in HSPCs compared with non-iron overload group. IOL may cause alterations in NK cells and HSPCs through the JNK and p38 pathways, and play a role in the transformation to AML from MDS.

Entities:  

Keywords:  Iron overload; JNK; Myelodysplastic syndromes; P38MAPK

Mesh:

Substances:

Year:  2017        PMID: 28405919     DOI: 10.1007/s12185-017-2237-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].

Authors:  Huijing Mi; Rong Fu; Huaquan Wang; Wen Qu; Erbao Ruan; Xiaoming Wang; Guojin Wang; Hong Liu; Yuhong Wu; Jia Song; Limin Xing; Jing Guan; Lijuan Li; Huijuan Jiang; Wei Zhang; Lanzhu Yue; Zonghong Shao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2014-03-18

2.  Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Authors:  Luca Malcovati; Matteo Giovanni Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Marina Boni; Erica Travaglino; Francesco Passamonti; Luca Arcaini; Margherita Maffioli; Paolo Bernasconi; Mario Lazzarino; Mario Cazzola
Journal:  J Clin Oncol       Date:  2005-09-26       Impact factor: 44.544

Review 3.  Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries.

Authors:  Stuart L Goldberg; Er Chen; Mitra Corral; Amy Guo; Nikita Mody-Patel; Andrew L Pecora; Marianne Laouri
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

4.  Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry.

Authors:  Roger M Lyons; Billie J Marek; Carole Paley; Jason Esposito; Lawrence Garbo; Nicholas DiBella; Guillermo Garcia-Manero
Journal:  Leuk Res       Date:  2013-11-13       Impact factor: 3.156

Review 5.  Iron overload in MDS-pathophysiology, diagnosis, and complications.

Authors:  Norbert Gattermann; Eliezer A Rachmilewitz
Journal:  Ann Hematol       Date:  2010-10-12       Impact factor: 3.673

6.  Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).

Authors:  Christian Rose; Sabine Brechignac; Dominique Vassilief; Laurent Pascal; Aspasia Stamatoullas; Agnes Guerci; Dalila Larbaa; François Dreyfus; Odile Beyne-Rauzy; Marie Pierre Chaury; Lydie Roy; Stephane Cheze; Pierre Morel; Pierre Fenaux
Journal:  Leuk Res       Date:  2010-02-02       Impact factor: 3.156

7.  Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.

Authors:  Chuang Huang; Kun Huang; Chi Wang; Zhen-Dong Jiang; Xing-Xing Li; Hong-Peng Wang; Hong-Yan Chen
Journal:  Oncol Rep       Date:  2009-07       Impact factor: 3.906

8.  Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

Authors:  Masaaki Takatoku; Takashi Uchiyama; Shinichiro Okamoto; Yuzuru Kanakura; Kenichi Sawada; Masao Tomonaga; Shinji Nakao; Tatsutoshi Nakahata; Mine Harada; Takashi Murate; Keiya Ozawa
Journal:  Eur J Haematol       Date:  2007-03-28       Impact factor: 2.997

9.  Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Authors:  Michel Delforge; Dominik Selleslag; Yves Beguin; Agnès Triffet; Philippe Mineur; Koen Theunissen; Carlos Graux; Fabienne Trullemans; Dominique Boulet; Koen Van Eygen; Lucien Noens; Steven Van Steenweghen; Jan Lemmens; Pascal Pierre; Randal D'hondt; Augustin Ferrant; Dries Deeren; Ann Van De Velde; Wim Wynendaele; Marc André; Robrecht De Bock; André Efira; Dimitri Breems; Anne Deweweire; Kurt Geldhof; Wim Pluymers; Amanda Harrington; Karen MacDonald; Ivo Abraham; Christophe Ravoet
Journal:  Leuk Res       Date:  2014-02-14       Impact factor: 3.156

10.  Modulation of intracellular iron levels by oxidative stress implicates a novel role for iron in signal transduction.

Authors:  Suman Deb; Erin E Johnson; Raquel L Robalinho-Teixeira; Marianne Wessling-Resnick
Journal:  Biometals       Date:  2009-02-04       Impact factor: 2.949

View more
  6 in total

Review 1.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

2.  S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.

Authors:  Chao Liu; Cheng-Wu Zhang; Shun Qiang Lo; Seok Ting Ang; Katherine Chee Meng Chew; Dejie Yu; Bing Han Chai; Bobby Tan; Fai Tsang; Yee Kit Tai; Bryce Wei Quan Tan; Mui Cheng Liang; Hwee Tong Tan; Jia Ying Tang; Mitchell Kim Peng Lai; John Jia En Chua; Maxey Ching Ming Chung; Sanjay Khanna; Kah-Leong Lim; Tuck Wah Soong
Journal:  J Neurosci       Date:  2018-08-13       Impact factor: 6.167

Review 3.  Influence of Vitamin C on Lymphocytes: An Overview.

Authors:  Gwendolyn N Y van Gorkom; Roel G J Klein Wolterink; Catharina H M J Van Elssen; Lotte Wieten; Wilfred T V Germeraad; Gerard M J Bos
Journal:  Antioxidants (Basel)       Date:  2018-03-10

4.  Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines.

Authors:  Shida Zhou; Xinxing Du; Junxia Xie; Jun Wang
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

5.  [Research progress of characteristics and mechanisms of iron overload affecting bone marrow hematopoiesis].

Authors:  L Huang; R Fu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-08-14

6.  Effects of signaling pathway inhibitors on hematopoietic stem cells.

Authors:  Yuyu Jiang; Zhaofeng Xu; Na Ma; Lizhi Yin; Caiqin Hao; Jing Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.